Structure Therapeutics (GPCR) Common Equity (2022 - 2026)
Quarterly Common Equity rose 75.48% to $1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Mar 2026, up 75.48% year-over-year, with the annual reading at $1.5 billion for FY2025, 75.34% up from the prior year.
Structure Therapeutics' Common Equity history spans 5 years, with the latest figure at $1.4 billion for Q1 2026.
- Common Equity came in at $1.4 billion for Q1 2026, down from $1.5 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.5 billion in Q4 2025 to a low of -$115.1 million in Q4 2022.
- The 5-year median for Common Equity is $453.0 million (2023), against an average of $538.3 million.
- Year-over-year, Common Equity skyrocketed 493.4% in 2023 and then fell 16.17% in 2025.
- Structure Therapeutics' Common Equity stood at -$115.1 million in 2022, then surged by 493.4% to $453.0 million in 2023, then surged by 90.93% to $864.8 million in 2024, then surged by 75.34% to $1.5 billion in 2025, then fell by 4.57% to $1.4 billion in 2026.
- Per Business Quant, the three most recent readings for GPCR's Common Equity are $1.4 billion (Q1 2026), $1.5 billion (Q4 2025), and $770.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 13.21 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 1.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Bn |
| Dec 31, 2025 | 1.52 Bn |
| Sep 30, 2025 | 770.02 Mn |
| Jun 30, 2025 | 772.08 Mn |
| Mar 31, 2025 | 824.64 Mn |
| Dec 31, 2024 | 864.84 Mn |
| Sep 30, 2024 | 896.80 Mn |
| Jun 30, 2024 | 921.03 Mn |
| Mar 31, 2024 | 429.82 Mn |
| Dec 31, 2023 | 452.97 Mn |
| Sep 30, 2023 | 192.96 Mn |
| Jun 30, 2023 | 214.42 Mn |
| Mar 31, 2023 | 236.35 Mn |
| Dec 31, 2022 | -115.14 Mn |
| Sep 30, 2022 | -103.91 Mn |
| Jun 30, 2022 | -92.10 Mn |
| Mar 31, 2022 | -77.23 Mn |